BioNano Genomics logo
BioNano Genomics BNGO
$ 0.28 -0.35%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

BioNano Genomics Financial Statements 2011-2024 | BNGO

Annual Financial Statements BioNano Genomics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

41 M 37 M 614 M 1.47 B 37.4 M 40.8 M - - - - - - -

Shares

34.2 M 28.9 M 277 M 133 M 34.3 M 10.1 M - - - - - - -

Historical Prices

1.2 1.28 2.22 11.1 1.03 4.1 - - - - - - -

Net Income

-232 M -133 M -72.4 M -41.1 M -29.8 M -18.5 M -23.4 M -18.8 M - - - - -

Revenue

36.1 M 27.8 M 18 M 8.5 M 10.1 M 12 M 9.51 M 6.79 M - - - - -

Cost of Revenue

26.6 M 21.9 M 14.1 M 5.73 M 6.77 M 8.71 M 6.03 M - - - - - -

Gross Profit

- - - 2.77 M 3.36 M 3.29 M 3.47 M 3.21 M - - - - -

Operating Income

-215 M -132 M -77.1 M -38.6 M -25.9 M -20.4 M -23.2 M - - - - - -

Interest Expense

5.12 M 298 K 927 K 2.52 M 2.29 M 1.38 M 591 K - - - - - -

EBITDA

-202 M -122 M -73.8 M -37.1 M -24.7 M -19.1 M -21.1 M -20.1 M - - - - -

Operating Expenses

- - - 41.3 M 29.2 M 23.7 M 26.1 M 24.4 M - - - - -

General and Administrative Expenses

93.5 M 88.6 M 58.5 M 31.1 M 20.2 M 14.2 M 14.1 M 13 M - - - - -

All numbers in USD currency

Quarterly Income Statement BioNano Genomics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

67.6 M 52.7 M 45.8 M 35 M 31.5 M 30.2 M 29.7 M 29 M 28.6 M 285 M 290 M 280 M 279 M 264 M 190 M 133 M 90.9 M 35.6 M 34.3 M 10.9 M 10.9 M 10.2 M 10.1 M 7.78 M 3.36 M 3.32 M 77.3 K 2.92 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-16.2 M -31.4 M - -113 M -38.9 M -37.1 M - -31.8 M -32.2 M -30 M - -20.8 M -18.8 M -9.95 M - -10.8 M -8.07 M -10.5 M -7.9 M -6.4 M -6.4 M -7.9 M -6.41 M -4.93 M -3.31 M -3.85 M 5.92 M -23.4 M 6.67 M 5.69 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

7.77 M 8.77 M - 9.32 M 8.66 M 7.42 M - 7.22 M 6.67 M 5.7 M - 4.66 M 3.86 M 3.17 M - 2.2 M 1.18 M 1.14 M 2.79 M 3.31 M 2.18 M 1.85 M 4.01 M 2.83 M 3.39 M 1.77 M 2.85 M 2.74 M 2.2 M 1.72 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

5.19 M 5.94 M - 6.57 M 6.35 M 5.34 M - 5.41 M 5.2 M 4.84 M - 3.5 M 2.42 M 2.12 M - 1.46 M 603 K 856 K 1.69 M 2.38 M 1.56 M 1.15 M 2.99 M 3.07 M 1.81 M 841 K 1.5 M 1.69 M 1.64 M 1.21 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-17 M -31.1 M - -113 M -39.2 M -37.8 M - -32.1 M -32.1 M -29.9 M - -20.7 M -16.5 M -11.2 M - -10.2 M -7.44 M -9.76 M - -5.68 M -6.84 M -6.18 M - -5.97 M -4.01 M -4.34 M - -5.03 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

363 K 122 K - 71 K -330 K 76 K - 73 K 74 K 77 K - 2 K 210 K 603 K - 589 K 561 K 761 K - 578 K 645 K 273 K - 404 K 408 K 302 K - 145 K - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -28.1 M - - - -34.7 M - -25.3 M -32.1 M -27.7 M - -19.2 M -16.5 M -10.7 M - -9.32 M -6.84 M -9.47 M - -5.41 M -6.58 M -5.92 M - -5.58 M -3.63 M -3.94 M - -4.79 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

11.6 M 19.5 M - 24.9 M 26.9 M 26 M - 21.2 M 21.8 M 20.3 M - 15.3 M 13.8 M 9.53 M - 8.66 M 5.61 M 7.37 M - 4.45 M 5.06 M 4.79 M - 3.22 M 3.49 M 2.9 M - 3.12 M - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency